{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:16:30Z","timestamp":1740104190763,"version":"3.37.3"},"reference-count":11,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1002\/ajh.24916","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T15:58:57Z","timestamp":1506614337000},"source":"Crossref","is-referenced-by-count":7,"title":["Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real\u2010life"],"prefix":"10.1002","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1163-6162","authenticated-orcid":false,"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioia","family":"Colafigli","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Molica","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Scalzulli","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Diverio","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7741-862X","authenticated-orcid":false,"given":"Roberto","family":"Latagliata","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Guarini","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto 1 Sapienza University Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.115"},{"key":"e_1_2_2_3_1","article-title":"Impact of treatment with frontline nilotinib vs imatinib on sustained deep molecular response in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"126","author":"Hochhaus A","year":"2015","journal-title":"Blood."},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.29"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.63"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2914"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5797"},{"key":"e_1_2_2_11_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.787.787","article-title":"Cessation of tyrosine kinase inhbitors treatment in chronic myeloid leukemia patients with deep molecular response: results of the Euro\u2010Ski trial","volume":"128","author":"Mahon FX","year":"2016","journal-title":"Blood."},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-462291"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24916","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:29:09Z","timestamp":1695572949000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1002\/ajh.24916"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24916","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"type":"print","value":"0361-8609"},{"type":"electronic","value":"1096-8652"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}